Literature DB >> 832184

Binding effects of concanavalin A on a coronavirus.

A S Greig, A M Bouillant.   

Abstract

Concanavalin A, a phytagglutinin, binds to the envelope of hemagglutinating encephalomyelitis virus, a Coronavirus. Concanavalin A treated virus suspensions lose their hemagglutination properties and there is a transient interference with infectivity. Electron micrographs show the Concanavalin A as a granular deposit adhering to the viral envelope and there is aggregation of the virus. Concanavalin A does not bind to virions stripped of their envelopes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832184      PMCID: PMC1277703     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  13 in total

1.  Identification of Hemagglutinin of Jack Bean with Concanavalin A.

Authors:  J B Sumner; S F Howell
Journal:  J Bacteriol       Date:  1936-08       Impact factor: 3.490

2.  Effect of Concanavalin A on cells infected with enveloped RNA viruses.

Authors:  H Becht; R Rott; H D Klenk
Journal:  J Gen Virol       Date:  1972-01       Impact factor: 3.891

3.  Action of snake venom on Rauscher virus.

Authors:  J H Monroe; G P Shibley; G Schidlovsky; T Nakai; A F Howatson; N W Wivel; T E O'Connor
Journal:  J Natl Cancer Inst       Date:  1968-01       Impact factor: 13.506

4.  Binding of Concanavalin A to the envelope of two murine RNA tumour viruses.

Authors:  J Calafat; P C Hageman
Journal:  J Gen Virol       Date:  1972-01       Impact factor: 3.891

5.  Further investigation on the fine structure of influenza virus.

Authors:  M V Nermut
Journal:  J Gen Virol       Date:  1972-12       Impact factor: 3.891

6.  Phospholipase isoenzymes from Naja naja venom. II. Phospholipase A and B activities.

Authors:  J Shiloah; C Klibansky; A De Vries
Journal:  Toxicon       Date:  1973-10       Impact factor: 3.033

7.  Location of the glycoprotein in the membrane of Sindbis virus.

Authors:  R W Compans
Journal:  Nat New Biol       Date:  1971-01-27

8.  Agglutination of an arbovirus by concanavalin A.

Authors:  J D Oram; D C Ellwood; G Appleyard; J L Stanley
Journal:  Nat New Biol       Date:  1971-09-08

9.  Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells.

Authors:  M Inbar; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

10.  Encephalomyelitis of swine caused by a haemagglutinating virus. VI. Morphology of the virus.

Authors:  A S Greig; C M Johnson; A M Bouillant
Journal:  Res Vet Sci       Date:  1971-07       Impact factor: 2.534

View more
  6 in total

Review 1.  Bioactive Based Nanocarriers for the Treatment of Viral Infections and SARS-CoV-2.

Authors:  Ravi Goyal; Rajni Bala; Rakesh K Sindhu; Mehrukh Zehravi; Reecha Madaan; Sarker Ramproshad; Banani Mondal; Abhijit Dey; Md Habibur Rahman; Simona Cavalu
Journal:  Nanomaterials (Basel)       Date:  2022-05-01       Impact factor: 5.719

Review 2.  Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies.

Authors:  Md Nasir Ahmed; Rownak Jahan; Veeranoot Nissapatorn; Polrat Wilairatana; Mohammed Rahmatullah
Journal:  Biomed Pharmacother       Date:  2021-12-07       Impact factor: 7.419

Review 3.  Plant lectins as potent Anti-coronaviruses, Anti-inflammatory, antinociceptive and antiulcer agents.

Authors:  Emadeldin Konozy; Makarim Osman; Amina Dirar
Journal:  Saudi J Biol Sci       Date:  2022-04-22       Impact factor: 4.052

4.  The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2.

Authors:  Javed Akhter; Grégory Quéromès; Krishna Pillai; Vahan Kepenekian; Samina Badar; Ahmed H Mekkawy; Emilie Frobert; Sarah J Valle; David L Morris
Journal:  Viruses       Date:  2021-03-06       Impact factor: 5.048

Review 5.  A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19).

Authors:  Amir Mirzaie; Mehrdad Halaji; Farhad Safarpoor Dehkordi; Reza Ranjbar; Hassan Noorbazargan
Journal:  Complement Ther Clin Pract       Date:  2020-06-17       Impact factor: 2.446

Review 6.  Beneficial Properties of Bromelain.

Authors:  Pawel Hikisz; Joanna Bernasinska-Slomczewska
Journal:  Nutrients       Date:  2021-11-29       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.